The development of new types of drugs based on DNA and RNA is happening at a rapid pace. The mRNA vaccines against COVID-19 are just one of many examples of DNA-based drugs on the market. Many are on the way, but the production of the necessary DNA is costly.
A research group at Aarhus University has now found an effective and inexpensive method for producing stable DNA sequences attached to chemical groups that e.g., ensures that the drugs are directed into the right cells.
